Sunitinib in Metastatic Renal Cell Carcinoma: Clinical Outcomes Across Risk Groups in a Turkish Oncology Group Kidney Cancer Consortium
| dc.contributor.author | Bolek, H. | |
| dc.contributor.author | Kuzu, O.F. | |
| dc.contributor.author | Sertesen Camoz, E. | |
| dc.contributor.author | Sim, S. | |
| dc.contributor.author | Sekmek, S. | |
| dc.contributor.author | Karakas, H. | |
| dc.contributor.author | Urun, Y. | |
| dc.date.accessioned | 2025-02-25T19:32:13Z | |
| dc.date.available | 2025-02-25T19:32:13Z | |
| dc.date.issued | 2025 | |
| dc.identifier.doi | 10.1002/cac2.70003 | |
| dc.identifier.issn | 2523-3548 | |
| dc.identifier.scopus | 2-s2.0-85217359773 | |
| dc.identifier.uri | https://doi.org/10.1002/cac2.70003 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14365/5947 | |
| dc.language.iso | en | en_US |
| dc.publisher | John Wiley and Sons Inc | en_US |
| dc.relation.ispartof | Cancer Communications | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.title | Sunitinib in Metastatic Renal Cell Carcinoma: Clinical Outcomes Across Risk Groups in a Turkish Oncology Group Kidney Cancer Consortium | en_US |
| dc.type | Letter | en_US |
| dspace.entity.type | Publication | |
| gdc.author.scopusid | 57211652341 | |
| gdc.author.scopusid | 59150821900 | |
| gdc.author.scopusid | 59547302000 | |
| gdc.author.scopusid | 59481213500 | |
| gdc.author.scopusid | 57226085393 | |
| gdc.author.scopusid | 58716740900 | |
| gdc.author.scopusid | 57203683804 | |
| gdc.bip.impulseclass | C5 | |
| gdc.bip.influenceclass | C5 | |
| gdc.bip.popularityclass | C5 | |
| gdc.coar.access | open access | |
| gdc.coar.type | text::letter | |
| gdc.collaboration.industrial | false | |
| gdc.description.department | İzmir Ekonomi Üniversitesi | en_US |
| gdc.description.departmenttemp | Bolek H., Department of Medical Oncology, Ankara University School of Medicine, Ankara, Türkiye, Ankara University Cancer Institute, Ankara, Türkiye; Kuzu O.F., Department of Medical Oncology, Gulhane Training and Research Hospital, University of Health Sciences, Ankara, Türkiye; Sertesen Camoz E., Department of Medical Oncology, Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Türkiye; Sim S., Department of Medical Oncology, Ege University School of Medicine, Izmir, Türkiye; Sekmek S., Department of Medical Oncology, Bilkent City Hospital, Ankara, Türkiye; Karakas H., Department of Medical Oncology, Bilkent City Hospital, Ankara, Türkiye; Isık S., Department of Medical Oncology, Marmara University School of Medicine, Istanbul, Türkiye; Guliyev M., Department of Medical Oncology, Cerrahpasa School of Medicine, Istanbul, Türkiye; Akkus A.F., Department of Medical Oncology, Trakya University School of Medicine, Edirne, Türkiye; Tural D., Department of Medical Oncology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul, Türkiye; Arslan C., Medical Point Hospital, Izmir University of Economics, Izmir, Türkiye; Goksu S.S., Department of Medical Oncology, Akdeniz University School of Medicine, Antalya, Türkiye; Sever O.N., Department of Medical Oncology, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Türkiye; Karadurmus N., Department of Medical Oncology, Gulhane Training and Research Hospital, University of Health Sciences, Ankara, Türkiye; Karacin C., Department of Medical Oncology, Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Türkiye; Sendur M.A.N., Department of Medical Oncology, Bilkent City Hospital, Ankara, Türkiye; Yekedüz E., Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States; Urun Y., Department of Medical Oncology, Ankara University School of Medicine, Ankara, Türkiye, Ankara University Cancer Institute, Ankara, Türkiye | en_US |
| gdc.description.endpage | 576 | |
| gdc.description.publicationcategory | Diğer | en_US |
| gdc.description.scopusquality | Q1 | |
| gdc.description.startpage | 572 | |
| gdc.description.volume | 45 | |
| gdc.description.wosquality | Q1 | |
| gdc.identifier.openalex | W4407348534 | |
| gdc.identifier.pmid | 39927571 | |
| gdc.index.type | Scopus | |
| gdc.oaire.accesstype | GOLD | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 1.0 | |
| gdc.oaire.influence | 2.5000004E-9 | |
| gdc.oaire.isgreen | true | |
| gdc.oaire.keywords | Neoplasms. Tumors. Oncology. Including cancer and carcinogens | |
| gdc.oaire.keywords | RC254-282 | |
| gdc.oaire.keywords | Letter to the Journal | |
| gdc.oaire.popularity | 3.5043568E-9 | |
| gdc.oaire.publicfunded | false | |
| gdc.openalex.collaboration | International | |
| gdc.openalex.fwci | 1.6502 | |
| gdc.openalex.normalizedpercentile | 0.79 | |
| gdc.openalex.toppercent | TOP 10% | |
| gdc.opencitations.count | 0 | |
| gdc.plumx.crossrefcites | 1 | |
| gdc.plumx.mendeley | 1 | |
| gdc.plumx.pubmedcites | 1 | |
| gdc.plumx.scopuscites | 1 | |
| gdc.scopus.citedcount | 1 | |
| relation.isOrgUnitOfPublication | e9e77e3e-bc94-40a7-9b24-b807b2cd0319 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | e9e77e3e-bc94-40a7-9b24-b807b2cd0319 |